文献速递消化道肿瘤与早癌消化内镜

高风险带蒂息肉切除后结直肠癌风险低

Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-02-05

在意大利 FIT 筛查队列中,87,248 例结肠镜检查后随访 7.25 年,低风险腺瘤患者结直肠癌发病率未显著升高(HR 1.18),高风险腺瘤患者显著升高(HR 1.53),但仅远端带蒂且无高级别异型增生的高风险腺瘤患者风险未增加(HR 0.87)。

要点

  • 低风险腺瘤切除后结直肠癌风险与 FIT+/结肠镜阴性者相当。
  • 高风险腺瘤中仅远端带蒂且无高级别异型增生者风险未增加。
  • 近端、非带蒂或高级别异型增生解释高风险腺瘤的额外风险。

核心结论

  • 高风险腺瘤患者结直肠癌发病率显著升高,但仅远端带蒂且无高级别异型增生者风险未增加。

主要发现

  • 中位随访 7.25 年共观察 635 例结直肠癌。
  • 低风险腺瘤患者结直肠癌发病率与 FIT+/结肠镜阴性组相比 HR 1.18(95%CI 0.92-1.53)。
  • 高风险腺瘤患者结直肠癌发病率显著升高,HR 1.53(95%CI 1.14-2.04)。
  • 近端、非带蒂或高级别异型增生任一风险因素可解释高风险腺瘤额外风险,HR 1.85(95%CI 1.36-2.52)。
  • 仅远端带蒂且无高级别异型增生者(占高风险腺瘤 39.2%)与 FIT 阴性组相比 HR 0.87(95%CI 0.59-1.28)。

关键数值与推荐

  • 低风险腺瘤:结直肠癌发病率 HR 1.18(95%CI 0.92-1.53),与 FIT+/结肠镜阴性组比较。
  • 高风险腺瘤:结直肠癌发病率 HR 1.53(95%CI 1.14-2.04),与 FIT+/结肠镜阴性组比较。
  • 高风险腺瘤伴至少一项风险因素(近端、非带蒂、高级别异型增生):HR 1.85(95%CI 1.36-2.52)。
  • 仅远端带蒂且无高级别异型增生:HR 0.87(95%CI 0.59-1.28),与 FIT 阴性组比较。

临床怎么用

  • FIT 筛查后高风险腺瘤患者需密切监测,但仅远端带蒂且无高级别异型增生者可考虑降低监测强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-fecal immunochemical test (FIT) colonoscopy represents a setting with an enriched prevalence of advanced adenomas. Due to an expected higher risk of colorectal cancer (CRC), postpolypectomy surveillance is recommended, generating a substantially increased load on endoscopy services. The aim of our study was to investigate postpolypectomy CRC risk in a screening population of FIT+ subjects after resection of low-risk adenomas (LRAs) or high-risk adenomas (HRAs). METHODS: We retrieved data from a cohort of patients undergoing postpolypectomy surveillance within a FIT-based CRC screening program in Italy between 2002 and 2017 and followed-up to December 2021. Main outcomes were postpolypectomy CRC incidence and mortality risks according to type of adenoma (LRA/HRA) removed at colonoscopy as well as morphology, size, dysplasia, and location of the index lesion. We adopted as comparators FIT+/colonoscopy-negative and FIT- patients. The absolute risk was calculated as the number of incident CRCs per 100,000 person-years of follow-up. We used Cox multivariable regression models to identify associations between CRC risks and patient- and polyp-related variables. RESULTS: Overall, we included 87,248 post-FIT+ colonoscopies (133 endoscopists). Of these, 42,899 (49.2%) were negative, 21,650 (24.8%) had an LRA, and 22,709 (26.0%) an HRA. After a median follow-up of 7.25 years, a total of 635 CRCs were observed. For patients with LRAs, CRC incidence (hazard ratio [HR], 1.18; 95% confidence interval [CI], 0.92-1.53) was not increased compared with the FIT+/colonoscopy-negative group, while for HRAs a significant increase in CRC incidence (HR, 1.53; 95% CI, 1.14-2.04) was found. The presence of 1 or more risk factors among proximal location, nonpedunculated morphology, and high-grade dysplasia explained most of this excess CRC risk in the HRA group (HR, 1.85; 95% CI, 1.36-2.52). Patients with only distal pedunculated polyps without high-grade dysplasia, representing 39.2% of HRA, did not have increased risk compared with the FIT- group (HR, 0.87; 95% CI, 0.59-1.28). CONCLUSIONS: CRC incidence is significantly higher in patients with HRAs diagnosed at colonoscopy. However, such excess risk does not appear to apply to patients with only distal pedunculated polyps without high-grade dysplasia, an observation that could potentially reduce the burden of surveillance in FIT programs.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zorzi M, Battagello J, Amidei CB, et al. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps. Clin Gastroenterol Hepatol. 2024. PMID: 38325601. doi:10.1016/j.cgh.2024.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。